dockets: FDA-2004-P-0096
This data as json
| id | agency_id | title | docket_type | last_modified | object_id |
|---|---|---|---|---|---|
| FDA-2004-P-0096 | FDA | ANDA Suitability for Acetaminophen, Butalbital Caffeine and Codeine Phosphate Capsules, 300 mg/50 mg/40 mg/30 mg-CLOSED | Nonrulemaking | 2021-09-01T01:02:10Z | 0b0000648046f4e0 |
Links from other tables
- 3 rows from docket_id in documents